Cargando…
A Large‐scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the third most lethal cancer worldwide. The lack of effective biomarkers for the early detection of HCC results in unsatisfactory curative treatments. Here, metabolite biomarkers were identified and validated for HCC diagnosis. A total of 1,448 subjects, including h...
Autores principales: | Luo, Ping, Yin, Peiyuan, Hua, Rui, Tan, Yexiong, Li, Zaifang, Qiu, Gaokun, Yin, Zhenyu, Xie, Xingwang, Wang, Xiaomei, Chen, Wenbin, Zhou, Lina, Wang, Xiaolin, Li, Yanli, Chen, Hongsong, Gao, Ling, Lu, Xin, Wu, Tangchun, Wang, Hongyang, Niu, Junqi, Xu, Guowang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680350/ https://www.ncbi.nlm.nih.gov/pubmed/28960374 http://dx.doi.org/10.1002/hep.29561 |
Ejemplares similares
-
Metabolomics Identifies Biomarker Pattern for Early Diagnosis of Hepatocellular Carcinoma: from Diethylnitrosamine Treated Rats to Patients
por: Zeng, Jun, et al.
Publicado: (2015) -
Serum metabolome and targeted bile acid profiling reveals potential novel biomarkers for drug-induced liver injury
por: Ma, Zhenhua, et al.
Publicado: (2019) -
Determination of candidate metabolite biomarkers associated with recurrence of HCV-related hepatocellular carcinoma
por: Liu, Zhicheng, et al.
Publicado: (2017) -
Metabolic Reprogramming and Its Relationship to Survival in Hepatocellular Carcinoma
por: Wang, Qingqing, et al.
Publicado: (2022) -
A weighted relative difference accumulation algorithm for dynamic metabolomics data: long-term elevated bile acids are risk factors for hepatocellular carcinoma
por: Zhang, Weijian, et al.
Publicado: (2015)